HQY HealthEquity, Inc.
HealthEquity, Inc. (HQY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $675.0K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| DILLON ADRIAN T 2 fills | Director | Sell 10b5-1 | 7,632 | $104.61 | $798.4K | 63,727 −10.7% of holding | |
| Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER | Sell 10b5-1 | 2,354 | $95.00 | $223.6K | 52,244 −4.3% of holding | |
| Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER | Sell 10b5-1 | 2,470 | $95.00 | $234.7K | 56,643 −4.2% of holding | |
| Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER | Sell 10b5-1 | 3,142 | $95.00 | $298.5K | 59,113 −5% of holding | |
| Ladd Delano | EVP, General Counsel | Sell 10b5-1 | 7,500 | $90.00 | $675.0K | 91,141 −7.6% of holding | |
| Wellborn Gayle Furgurson | Director | Sell 10b5-1 | 2,439 | $90.00 | $219.5K | 19,733 −11% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.